Browse the evidence

Person-specific characteristics (genetic, hormonal, psychosocial, and behavioral) significantly predict individual variability in weight loss response to obesity interventions, making precision medicine strategies potentially more effective than broad application of treatments.

Stop assuming a single diet or exercise plan works for everyone. Your body's unique genetics, hormones, and psychology dictate how you respond to treatment. Instead of blindly following a generic plan, look for early signs of response (like weight loss in the first few weeks) to decide whether to continue or switch strategies. If you have specific genetic conditions (like leptin deficiency), targeted medical therapies may be available, but for most, success depends on matching the intervention to your specific biological and psychological profile.

Higher baseline levels of inflammation (indicated by insulin, IL-6, adipose tissue inflammation, cortisol, and leptin) are associated with a worse weight loss response to lifestyle modification therapy.

If you have high insulin or inflammation, standard diet and exercise advice may be less effective for you. This doesn't mean you can't lose weight, but it may require more targeted approaches, such as specific dietary changes (e.g., low-carbohydrate vs. low-fat) or medications that address these specific hormonal issues. Consult a provider to check these markers.

Daily supplementation with a combination of nicotinamide riboside (NR) and pterostilbene (NRPT) at the recommended dose significantly reduces circulating levels of hepatic inflammation markers (ALT and GGT) and toxic lipids (ceramide 14:0) in adults with Non-Alcoholic Fatty Liver Disease (NAFLD) over 6 months, without reducing hepatic fat fraction.

If you have NAFLD, a specific combination of Nicotinamide Riboside and Pterostilbene (taken daily at the recommended dose) may help lower liver inflammation markers (ALT, GGT) and toxic lipids over 6 months. However, do not expect this supplement to reduce the actual amount of fat in your liver, as the study showed no improvement in hepatic fat fraction compared to a placebo.

Obesity is associated with high prevalence of micronutrient deficiencies (e.g., Vitamin D, Iron, B12) due to physiological changes like increased volume of distribution, sequestration in adipose tissue, and inflammation-induced malabsorption (e.g., hepcidin blocking iron).

If you have obesity, assume you may be deficient in key micronutrients like Vitamin D, Iron, and B12, regardless of how much you eat. Focus on nutrient-dense foods and discuss screening with your doctor, as standard weight loss diets can sometimes worsen these deficiencies.

Strict weight reduction diets (Low-carb, Ketogenic, Intermittent Fasting, VLCD) significantly increase the risk of micronutrient deficiencies compared to balanced or low-fat diets.

If you use a restrictive diet like Keto or Intermittent Fasting to lose weight, you are at high risk for missing essential nutrients. You must actively supplement or carefully plan your meals to include these nutrients, as the diet itself limits your intake.

Coconut oil consumption improves cardiovascular lipid profiles by significantly increasing HDL-C and lowering the LDL-C/HDL-C ratio compared to butter, despite raising LDL-C levels relative to unsaturated vegetable oils.

If you are replacing butter with coconut oil, expect your HDL (good) cholesterol to rise significantly, which improves your overall lipid ratio. While your LDL (bad) cholesterol may also rise, the net effect on the LDL/HDL ratio is often more favorable than with butter. However, this does not mean coconut oil is superior to unsaturated vegetable oils like olive or safflower oil for lowering LDL; it is simply a better saturated fat option than animal fats.

Replacing saturated fatty acids (SFA) from dairy foods with polyunsaturated fatty acids (PUFA) reduces LDL cholesterol but does not consistently reduce cardiovascular disease (CVD) risk or mortality, suggesting that LDL-C reduction alone is not a reliable predictor of CVD outcomes when the source is dairy.

Current guidelines suggest limiting saturated fats to reduce heart disease risk. However, this review indicates that replacing dairy saturated fats with polyunsaturated fats lowers LDL cholesterol but does not necessarily lower your actual risk of heart attacks or death. This suggests that simply counting saturated fat grams may be less important than the overall food matrix (e.g., eating whole dairy products) and other lipid markers like the LDL particle size.

High intake of saturated fatty acids from dairy foods is associated with neutral or negative (protective) associations with cardiovascular disease risk, unlike SFAs from other sources which may increase risk.

You do not need to restrict dairy foods to manage heart health risk. While general guidelines limit saturated fats, evidence suggests that the specific fats found in dairy (like C15:0 and C17:0) are associated with neutral or even protective effects on cardiovascular disease, unlike saturated fats from other sources.

Semaglutide administration significantly reduces the incidence of atrial fibrillation by 42% compared to placebo in patients at high cardiovascular risk, primarily those with type 2 diabetes or obesity.

If you have type 2 diabetes or are overweight with high heart disease risk, ask your doctor about semaglutide. This medication has been shown to significantly lower your chance of developing atrial fibrillation, a common heart rhythm problem, regardless of whether you take it as a pill or a weekly injection. This benefit exists even if you do not have diabetes.

Weight maintainers in older adults with type 2 diabetes exhibit high variability in physical activity levels, with many maintaining >= 10% weight loss while engaging in less than the recommended 150-250 min/wk of MVPA.

If you have type 2 diabetes and are maintaining your weight, you do not need to force yourself to exercise 4+ hours a week if it is unsustainable. This study shows that many people maintain significant weight loss with less than 150 minutes of moderate-to-vigorous activity per week. Focus on what keeps your weight stable, whether that is moderate activity combined with strict diet, or other lifestyle factors. Do not let the lack of high-volume exercise invalidate your success.

Behavioral weight management programs (BWMPs) produce sustained improvements in cardiometabolic risk factors (blood pressure, lipid profile, glycemic control) for at least 5 years after program end, despite significant weight regain.

If you participate in a structured weight loss program, expect your blood pressure, cholesterol, and blood sugar to improve significantly. Even if you regain some weight after the program ends, these health benefits will likely persist for at least five years. Do not be discouraged by partial weight regain; the metabolic improvements are durable.

Saturated fatty acids (SFA) promote greater long-term weight gain compared to unsaturated fatty acids (MUFA/PUFA) primarily due to lower diet-induced thermogenesis (DIT) and reduced energy expenditure, despite potentially stimulating appetite-regulating hormones like CCK and PYY more strongly.

Focus on the quality of fat rather than just eliminating it. Replacing saturated fats (found in butter, fatty meats) with unsaturated fats (olive oil, nuts, fish) may support weight control by boosting your body's energy expenditure, even if total calories remain similar.

Monounsaturated fatty acids (MUFA) and Polyunsaturated fatty acids (PUFA) stimulate higher diet-induced thermogenesis (DIT) and energy expenditure compared to Saturated fatty acids (SFA), which may aid in long-term weight maintenance despite having weaker effects on acute appetite suppression.

Incorporate more unsaturated fats (like olive oil, avocados, nuts) into your diet. Even if they don't make you feel as full as other foods, they may help your body burn more calories at rest and after meals compared to saturated fats.

Maintaining non-smoking status, high diet quality, and high leisure-time physical activity significantly reduces the risk of atherothrombotic ischemic stroke, with benefits independent of established comorbidities.

To lower your risk of atherothrombotic stroke, focus on three key behaviors: do not smoke, maintain a high-quality diet (rich in fish, vegetables, fiber, and healthy fats), and engage in high levels of leisure-time physical activity. These benefits hold true even if you have existing conditions like high blood pressure or diabetes. Do not rely on BMI alone as a risk indicator; prioritize these active lifestyle factors.

Short-term consumption of fast-food meals (a subset of UPFs) increases bile-tolerant bacteria (Collinsella, Parabacteroides, Bilophila) and decreases fiber-fermenting bacteria (Lachnospiraceae, Butyricicoccus).

Eating fast food for just 4 days can shift your gut bacteria, increasing bile-tolerant types and decreasing fiber-fermenting types. To maintain a healthy microbiome, limit fast food frequency and prioritize fiber-rich foods.

Weight cycling (yo-yo dieting) is associated with increased cardiovascular risk and morbidity, whereas sustained weight loss or maintenance reduces risk.

Avoid yo-yo dieting. Repeatedly losing and regaining weight increases your risk of heart disease. Focus on sustainable weight loss or maintenance. If you struggle with weight cycling, seek professional help to establish stable habits.

GLP-1 receptor agonists (Liraglutide, Semaglutide, Tirzepatide) are effective for chronic weight management in obese patients, but improper use without clinical indication can lead to serious side effects.

GLP-1 drugs like Semaglutide and Tirzepatide are effective for weight loss in obese patients with comorbidities. However, they are prescription medications with serious side effects. Do not use them without medical indication or supervision. Follow your doctor's dosage and monitoring plan.

Long-term adherence to a low-carbohydrate diet (LCD) starting in young adulthood is associated with an increased risk of coronary artery calcium (CAC) progression in middle age, particularly when carbohydrates are replaced by animal-based protein and fat rather than plant-based sources.

If you follow a low-carbohydrate diet, especially one that started in your 20s or 30s, be mindful of what replaces the carbohydrates. This study suggests that replacing carbs with animal proteins and fats (like red meat, butter, cheese) is linked to increased coronary artery calcium progression, a marker of heart disease risk. To mitigate this risk, consider replacing carbohydrates with plant-based proteins and fats (like nuts, seeds, legumes, vegetables) instead. Long-term animal-based low-carb diets should be approached with caution regarding cardiovascular health.

Excess caloric intake, particularly from carbohydrates (fructose/glucose) and saturated fats, drives de novo lipogenesis and hepatic fat accumulation, whereas unsaturated fats (omega-3) may reduce liver fat.

Focus on reducing added sugars (especially fructose/sweetened beverages) and saturated fats. Replace them with unsaturated fats (like omega-3s) and whole food carbohydrates. Total calories matter, but what you eat matters more for your liver.

Tirzepatide treatment (5-15 mg once weekly) significantly improves health-related quality of life (HRQoL), including physical function and psychosocial well-being, compared to placebo in adults with obesity or overweight.

If you have obesity or overweight, treatment with tirzepatide (5-15 mg once weekly) along with lifestyle changes significantly improves your quality of life, physical function, and mental well-being compared to placebo. The greater the weight loss achieved (especially ≥5%), the greater the improvement in how you feel and function daily.

Greater degrees of weight reduction achieved with tirzepatide are associated with greater improvements in health-related quality of life (HRQoL), particularly when weight loss is ≥5%.

With tirzepatide, you don't need to lose a massive amount of weight to see benefits. Losing 5% or more of your body weight is associated with noticeable improvements in how you feel and function, with greater losses leading to even better outcomes.

High consumption of 'savory-fatty' tasting foods is associated with increased total energy intake and overweight status, whereas 'neutral' tasting foods are consumed in lower proportions by high-energy consumers.

Focus on the taste profile of your diet, not just processing levels. High intake of 'savory-fatty' foods (common in many processed dishes) is strongly linked to higher energy consumption and overweight status in this population. To manage weight, consider reducing the proportion of energy derived from savory-fatty clusters and increasing neutral-tasting foods, which were consumed in higher proportions by those with lower energy intake.

The association between sweet taste and sugar content is weaker in ultra-processed foods compared to unprocessed foods, potentially due to the use of non-saccharide sweeteners.

Be aware that sweet taste in ultra-processed foods does not always correlate with high sugar content. Manufacturers may use non-saccharide sweeteners to maintain sweetness while reducing sugar, which can disrupt your body's ability to predict energy intake based on taste alone.

Lifestyle modification resulting in 7% weight loss and 150-175 minutes per week of physical activity can reduce the relative risk of obesity-related cancer by 16%, suggesting the effects of obesity on cancer risk may be reversible.

Aim for a 7% weight loss and 175 minutes of physical activity per week. While the cancer risk reduction in the major trial was not statistically significant, the trend suggests that maintaining a healthy weight through diet and exercise is a powerful way to lower your cancer risk.